Cargando…
Impact of histotypes on preferential organ‐specific metastasis in triple‐negative breast cancer
BACKGROUND: The distant metastasis was the most predictive characters of poor prognosis for triple‐negative breast cancer (TNBC). We aimed to evaluate the correlation between patient characters and preferential distant metastatic sites (DMS) and its effects on prognosis. METHODS: Using the 2010‐2014...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997059/ https://www.ncbi.nlm.nih.gov/pubmed/31814295 http://dx.doi.org/10.1002/cam4.2759 |
_version_ | 1783493614840578048 |
---|---|
author | Li, Yaming Su, Peng Wang, Yifei Zhang, Hanwen Liang, Yiran Zhang, Ning Song, Xiaojin Li, Xiaoyan Li, Jie Yang, Qifeng |
author_facet | Li, Yaming Su, Peng Wang, Yifei Zhang, Hanwen Liang, Yiran Zhang, Ning Song, Xiaojin Li, Xiaoyan Li, Jie Yang, Qifeng |
author_sort | Li, Yaming |
collection | PubMed |
description | BACKGROUND: The distant metastasis was the most predictive characters of poor prognosis for triple‐negative breast cancer (TNBC). We aimed to evaluate the correlation between patient characters and preferential distant metastatic sites (DMS) and its effects on prognosis. METHODS: Using the 2010‐2014 Surveillance, Epidemiology, and End Results Program (SEER) data, patients with TNBC were classified into eight histologic subtypes. Patient characters were compared using a chi‐squared test. Logistic regression was used for identification of predictive factors. The log‐rank testing was utilized with disease‐specific survival (DSS) and overall survival (OS) as the primary outcomes. RESULTS: A total of 23 270 patients with TNBC were involved, including 1544 patients with distant metastatic cancer. Bone metastasis was diagnosed in 559 cases, brain metastasis in 124 cases, liver metastasis found in 369 cases and lung metastasis in 492 cases. Histologic subtypes including metaplastic breast carcinoma and invasive lobular carcinoma showed significant differences in preferential DMS compared with invasive ductal carcinoma. Furthermore, we found different histologic subtypes with specific DMS showed various prognosis. We also evaluated different DMS of specific histologic subtypes showed different prognosis. CONCLUSION: Certain histologic subtypes of breast cancer are associated with preferential DMS and prognosis; this knowledge may help to further understand the mechanism of breast cancer metastasis and to monitor the prognosis of patients with TNBC. |
format | Online Article Text |
id | pubmed-6997059 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-69970592020-02-05 Impact of histotypes on preferential organ‐specific metastasis in triple‐negative breast cancer Li, Yaming Su, Peng Wang, Yifei Zhang, Hanwen Liang, Yiran Zhang, Ning Song, Xiaojin Li, Xiaoyan Li, Jie Yang, Qifeng Cancer Med Clinical Cancer Research BACKGROUND: The distant metastasis was the most predictive characters of poor prognosis for triple‐negative breast cancer (TNBC). We aimed to evaluate the correlation between patient characters and preferential distant metastatic sites (DMS) and its effects on prognosis. METHODS: Using the 2010‐2014 Surveillance, Epidemiology, and End Results Program (SEER) data, patients with TNBC were classified into eight histologic subtypes. Patient characters were compared using a chi‐squared test. Logistic regression was used for identification of predictive factors. The log‐rank testing was utilized with disease‐specific survival (DSS) and overall survival (OS) as the primary outcomes. RESULTS: A total of 23 270 patients with TNBC were involved, including 1544 patients with distant metastatic cancer. Bone metastasis was diagnosed in 559 cases, brain metastasis in 124 cases, liver metastasis found in 369 cases and lung metastasis in 492 cases. Histologic subtypes including metaplastic breast carcinoma and invasive lobular carcinoma showed significant differences in preferential DMS compared with invasive ductal carcinoma. Furthermore, we found different histologic subtypes with specific DMS showed various prognosis. We also evaluated different DMS of specific histologic subtypes showed different prognosis. CONCLUSION: Certain histologic subtypes of breast cancer are associated with preferential DMS and prognosis; this knowledge may help to further understand the mechanism of breast cancer metastasis and to monitor the prognosis of patients with TNBC. John Wiley and Sons Inc. 2019-12-09 /pmc/articles/PMC6997059/ /pubmed/31814295 http://dx.doi.org/10.1002/cam4.2759 Text en © 2019 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Cancer Research Li, Yaming Su, Peng Wang, Yifei Zhang, Hanwen Liang, Yiran Zhang, Ning Song, Xiaojin Li, Xiaoyan Li, Jie Yang, Qifeng Impact of histotypes on preferential organ‐specific metastasis in triple‐negative breast cancer |
title | Impact of histotypes on preferential organ‐specific metastasis in triple‐negative breast cancer |
title_full | Impact of histotypes on preferential organ‐specific metastasis in triple‐negative breast cancer |
title_fullStr | Impact of histotypes on preferential organ‐specific metastasis in triple‐negative breast cancer |
title_full_unstemmed | Impact of histotypes on preferential organ‐specific metastasis in triple‐negative breast cancer |
title_short | Impact of histotypes on preferential organ‐specific metastasis in triple‐negative breast cancer |
title_sort | impact of histotypes on preferential organ‐specific metastasis in triple‐negative breast cancer |
topic | Clinical Cancer Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997059/ https://www.ncbi.nlm.nih.gov/pubmed/31814295 http://dx.doi.org/10.1002/cam4.2759 |
work_keys_str_mv | AT liyaming impactofhistotypesonpreferentialorganspecificmetastasisintriplenegativebreastcancer AT supeng impactofhistotypesonpreferentialorganspecificmetastasisintriplenegativebreastcancer AT wangyifei impactofhistotypesonpreferentialorganspecificmetastasisintriplenegativebreastcancer AT zhanghanwen impactofhistotypesonpreferentialorganspecificmetastasisintriplenegativebreastcancer AT liangyiran impactofhistotypesonpreferentialorganspecificmetastasisintriplenegativebreastcancer AT zhangning impactofhistotypesonpreferentialorganspecificmetastasisintriplenegativebreastcancer AT songxiaojin impactofhistotypesonpreferentialorganspecificmetastasisintriplenegativebreastcancer AT lixiaoyan impactofhistotypesonpreferentialorganspecificmetastasisintriplenegativebreastcancer AT lijie impactofhistotypesonpreferentialorganspecificmetastasisintriplenegativebreastcancer AT yangqifeng impactofhistotypesonpreferentialorganspecificmetastasisintriplenegativebreastcancer |